Stemsation International Stock Today

STSN Stock  USD 0.01  0.0002  3.64%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Stemsation International is selling at 0.0057 as of the 22nd of March 2025; that is 3.64 percent increase since the beginning of the trading day. The stock's open price was 0.0055. Stemsation International has about a 27 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. StemSation International, Inc. is headquartered in Boca Raton, Florida. Sternsation International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 24.76 M outstanding shares. More on Stemsation International

Moving against Stemsation Pink Sheet

  0.74VLKAF Volkswagen AGPairCorr
  0.74VWAGY Volkswagen AG 110PairCorr
  0.71VWAPY Volkswagen AG PrefPairCorr
  0.69VLKPF Volkswagen AG VZOPairCorr
  0.53TAK Takeda PharmaceuticalPairCorr
  0.46TKPHF Takeda PharmaceuticalPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Stemsation Pink Sheet Highlights

Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Stemsation International [STSN] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stemsation International's market, we take the total number of its shares issued and multiply it by Stemsation International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Stemsation International conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 24.76 M outstanding shares. Stemsation International currently holds about 178 in cash with (181) of positive cash flow from operations.
Check Stemsation International Probability Of Bankruptcy

Stemsation International Risk Profiles

Stemsation Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Stemsation International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Stemsation International Corporate Management

Other Information on Investing in Stemsation Pink Sheet

Stemsation International financial ratios help investors to determine whether Stemsation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemsation with respect to the benefits of owning Stemsation International security.